Director/PDMR Shareholding

RNS Number : 0429C
Integumen PLC
10 April 2017
 

10 April 2017 

Integumen plc

('Integumen' or the 'Company')

Director/PDMR Shareholding

Integumen plc (AIM: EVRH) announces the following.

Director shareholding

As part of the Placing and Admission (which took place on 5 April) Director Chris Bell subscribed for 200,000 Placing Shares pursuant to the Placing, at the Placing Price of 5p.

His resultant holding of shares is as follows:

Director

Shares 

% of share capital

 

C Bell

200,000

0.12%   

 

 

 

 

 

 

 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

 

Chris Bell

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Director

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Integumen plc

b)

 

LEI

 

 

N/A

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary shares of £0.01 each

 

 ISIN: GB00BYWJ6269

 

 

 

b)

 

Nature of the transaction

 

 

Placing

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

5p per share

 

200,000

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

 

N/A

 

 

 

 

 

 

e)

 

Date of the transaction

 

 

5 April 2017

f)

 

Place of the transaction

 

 

Off-market

- Ends -

 

For further information:

 

Integumen plc

Declan Service, CEO

 

+ 353 (0) 87 770 5506  

SPARK Advisory Partners Limited

(Nominated Adviser)

 

Neil Baldwin/Sean Wyndham-Quin

+44 (0) 113 370 8974

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHEAPLEFAKXEEF
UK 100

Latest directors dealings